Vernon Bernardino


FBR Reiterates Bullish Stance On Aurinia Pharmaceuticals Inc (AUPH) Following Development Updates

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on …

FBR Boosts Price Target For Aurinia Pharmaceuticals Inc (AUPH) As Balance Sheet Improves

FBR analyst Vernon Bernardino, one of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) biggest bulls, is out today with …

Aurinia Pharmaceuticals Inc (AUPH): A Hot Acquisition Target in 2017

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are surging 18% today following fourth-quarter and full year 2016 …

Aurinia Pharmaceuticals Inc (AUPH) Shares Continue to Soar as Voclosporin Success Opens Partnership Possibilities

  Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares have been skyrocketing following the biotech firm’s major success …

FBR Envisions Bullish Forecast for Aurinia Pharmaceuticals Inc (AUPH) Under New CEO

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced on Monday that Richard Glickman would be taking on new …

FBR Downgrades Galena Biopharma Inc (GALE) Right as Stock Skyrockets 30%

This morning, the firm revealed an independent group of experts has judged its breast cancer …

FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and …

FBR Offers Commentary on Aurinia Pharmaceuticals Inc (AUPH) Following Receipt of FDA Meeting Minutes

FBR analyst Vernon Bernardino came out with some commentary on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), after …

FBR Analyst Adjusts Price Target for Galena Biopharma Inc (GALE) Post Reverse Stock Split

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on …

FBR Chimes in on Novavax, Inc. (NVAX) Following Analyst Day

In a research report released Friday, FBR Capital analyst Vernon Bernardino reiterated an Outperform rating …